We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Boise Cascade
BCC
$3.02B
| $19.3M | 0.01% |
324,961
-79,910
| -20% | -$5.14M |
|
1027
Morningstar
MORN
$7.53B
| $19.3M | 0.01% |
91,005
-1,225
| -1% | -$291K |
|
1028
Associated Banc-Corp
ASB
$5.91B
| $19.3M | 0.01% |
961,952
+364,070
| +61% | +$7.32M |
|
1029
Inspire Medical Systems
INSP
$1.74B
| $19.3M | 0.01% |
108,855
+9,929
| +10% | +$2M |
|
1030
Valley National Bancorp
VLY
$8.04B
| $19.3M | 0.01% |
1,785,771
-56,762
| -3% | -$655K |
|
1031
Privia Health
PRVA
$2.87B
| $19.3M | 0.01% |
565,534
+202,626
| +56% | +$7.49M |
|
1032
Cousins Properties
CUZ
$4.88B
| $19.2M | 0.01% |
822,663
-137,613
| -14% | -$3.89M |
|
1033
Valaris
VAL
$5.47B
| $19.1M | 0.01% |
387,372
-21,897
| -5% | -$1.05M |
|
1034
Avista
AVA
$3.24B
| $19.1M | 0.01% |
515,506
+238,745
| +86% | +$9.99M |
|
1035
Southern Copper
SCCO
$166B
| $19M | 0.01% |
454,816
-266
| -0.1% | -$11.8K |
|
1036
Community Bank
CBU
$3.41B
| $19M | 0.01% |
316,211
+9,672
| +3% | +$637K |
|
|
PPBI
1037
DELISTED
Pacific Premier Bancorp
PPBI
| $19M | 0.01% |
612,900
-36,298
| -6% | -$1.18M |
|
1038
Cleveland-Cliffs
CLF
$6.99B
| $19M | 0.01% |
1,408,046
-70,729
| -5% | -$1.18M |
|
|
LHCG
1039
DELISTED
LHC Group LLC
LHCG
| $19M | 0.01% |
115,891
+9,100
| +9% | +$1.48M |
|
1040
A.O. Smith
AOS
$8.7B
| $18.9M | 0.01% |
389,851
-10,399
| -3% | -$597K |
|
1041
First Citizens BancShares
FCNCA
$25.3B
| $18.9M | 0.01% |
23,735
-654
| -3% | -$511K |
|
|
KDNY
1042
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $18.9M | 0.01% |
961,258
+336,054
| +54% | +$6.74M |
|
1043
Cable One
CABO
$212M
| $18.9M | 0.01% |
22,147
-2,120
| -9% | -$2.62M |
|
1044
AXIS Capital
AXS
$7.55B
| $18.9M | 0.01% |
384,230
-4,011
| -1% | -$212K |
|
1045
Grupo Cibest SA
CIB
$21.1B
| $18.9M | 0.01% |
774,347
+12,131
| +2% | +$350K |
|
1046
Stem
STEM
$52.7M
| $18.8M | 0.01% |
70,588
+38,766
| +122% | +$9.91M |
|
1047
News Corp Class A
NWSA
$15.4B
| $18.8M | 0.01% |
1,244,769
-27,531
| -2% | -$462K |
|
1048
GXO Logistics
GXO
$5.55B
| $18.8M | 0.01% |
535,481
+49,329
| +10% | +$2.18M |
|
|
THS
1049
DELISTED
Treehouse Foods
THS
| $18.8M | 0.01% |
442,553
+245,324
| +124% | +$11M |
|
1050
Harmony Biosciences
HRMY
$2.24B
| $18.7M | 0.01% |
423,255
-69,961
| -14% | -$3.41M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.